Ross L Prentice

发表

Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation.

Lihong Qi, Ross L Prentice, R. Prentice, 2006, Biostatistics.

Robust methods to correct for measurement error when evaluating a surrogate marker

Raymond J Carroll, Tanya P Garcia, Layla Parast, 2020, Biometrics.

Two-stage biomarker panel study and estimation allowing early termination for futility.

Yingye Zheng, Ziding Feng, Shanshan Zhao, 2015, Biostatistics.

A penalized EM algorithm incorporating missing data mechanism for Gaussian parameter estimation

Ross L Prentice, R. Prentice, Lin S. Chen, 2014, Biometrics.

Empirical evaluation of gene and environment interactions: methods and potential.

Ross L Prentice, R. Prentice, 2011, Journal of the National Cancer Institute.

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.

Lewis H Kuller, Charles Kooperberg, Garnet L Anderson, 2008, American journal of epidemiology.

Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.

Jacob Kennedy, Yuzheng Zhang, Sharon J Pitteri, 2010, Cancer research.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Charles Kooperberg, Garnet L Anderson, Ross L Prentice, 2002, JAMA.

Statistical Issues Arising in the Women's Health Initiative

Garnet L Anderson, Ross L Prentice, R. Prentice, 2005, Biometrics.

Simultaneously testing for marginal genetic association and gene-environment interaction.

Benjamin A. Logsdon, Li Hsu, James Y Dai, 2012, American journal of epidemiology.

Chronic disease prevention: public health potential and research needs

Ross L Prentice, R. Prentice, 2004, Statistics in medicine.

Use of a Urinary Sugars Biomarker to Assess Measurement Error in Self-Reported Sugars Intake in the Nutrition and Physical Activity Assessment Study (NPAAS)

Johanna W Lampe, Victor Kipnis, Douglas Midthune, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Calcium plus vitamin D supplementation and the risk of colorectal cancer.

John Robbins, Thomas E Rohan, Lewis H Kuller, 2006, The New England journal of medicine.

Implementation of the Women's Health Initiative study design.

Scott Davis, Garnet L Anderson, Ross L Prentice, 2003, Annals of epidemiology.

Evaluation and comparison of food records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers.

Bette Caan, Ying Huang, Yasmin Mossavar-Rahmani, 2011, American journal of epidemiology.

Logistic Regression with Exposure Biomarkers and Flexible Measurement Error

Ross L Prentice, R. Prentice, Ching-Yun Wang, 2007, Biometrics.

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.

Peter Kraft, Sara Lindström, I-Min Lee, 2014, Human molecular genetics.

Pooled versus individual genotyping in a breast cancer genome‐wide association study

Lihong Qi, Ying Huang, Ross L Prentice, 2010, Genetic epidemiology.

Semiparametric Maximum Likelihood Estimation in Normal Transformation Models for Bivariate Survival Data.

Yi Li, Xihong Lin, Ross L Prentice, 2008, Biometrika.

Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for potassium and sodium intake.

Victor Kipnis, Laurence S Freedman, Donna Spiegelman, 2015, American journal of epidemiology.

Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative.

Pamela A Shaw, Bette Caan, Suzanne Satterfield, 2008, American journal of epidemiology.

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.

Steven Gallinger, Peter Kraft, Nazneen Rahman, 2016, Cancer research.

Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative.

Ying Huang, Yasmin Mossavar-Rahmani, Ross L Prentice, 2011, The American journal of clinical nutrition.

Two-stage testing procedures with independent filtering for genome-wide gene-environment interaction.

James Y Dai, Charles Kooperberg, James Y. Dai, 2012, Biometrika.

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Lewis H Kuller, Robert B Wallace, Charles Kooperberg, 2013, JAMA.

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

Garnet L Anderson, Ross L Prentice, R. Langer, 2006, American journal of epidemiology.

Discovery of common and rare genetic risk variants for colorectal cancer

Mathieu Lemire, Steven Gallinger, Michael Wainberg, 2018, Nature Genetics.

Estimation of the 2-sample hazard ratio function using a semiparametric model.

Ross L Prentice, Song Yang, R. Prentice, 2011, Biostatistics.

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.

Lewis H Kuller, Charles Kooperberg, Garnet L Anderson, 2008, American journal of epidemiology.

Pooled results from 5 validation studies of dietary self-report instruments using recovery biomarkers for energy and protein intake.

Victor Kipnis, Laurence S Freedman, Douglas Midthune, 2014, American journal of epidemiology.

Mixed Discrete and Continuous Cox Regression Model

John D Kalbfleisch, Ross L Prentice, J. Kalbfleisch, 2003, Lifetime data analysis.

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.

Lewis H Kuller, Matthew Allison, Garnet L Anderson, 2009, American journal of epidemiology.

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

Ross L Prentice, Garnet Anderson, R. Langer, 2005, American journal of epidemiology.

Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease

C Y Wang, Ruth Patterson, Ross L Prentice, 2002, Public Health Nutrition.

The women's health initiative: lessons learned.

Garnet L Anderson, Ross L Prentice, R. Prentice, 2008, Annual review of public health.

National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

John Robbins, Lawrence Phillips, Bette Caan, 2004, BMJ : British Medical Journal.

Factors relating to eating style, social desirability, body image and eating meals at home increase the precision of calibration equations correcting self-report measures of diet using recovery biomarkers: findings from the Women’s Health Initiative

Ying Huang, Yasmin Mossavar-Rahmani, Ross L Prentice, 2013, Nutrition Journal.

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Lihong Qi, JoAnn E Manson, Garnet L Anderson, 2013, Journal of the National Cancer Institute.

Material Supplementary Cited Articles E-mail Alerts Characterization of Gene–environment Interactions for Colorectal Cancer Susceptibility Loci American Association for Cancer Research

Mathieu Lemire, Steven Gallinger, Yan Liu, 2022 .

Regression calibration in nutritional epidemiology: example of fat density and total energy in relationship to postmenopausal breast cancer.

Jeannette Beasley, Ying Huang, Ross L Prentice, 2013, American journal of epidemiology.